Truist Securities expressed a positive outlook on Boston Scientific (NYSE:BSX) shares, raising the price target to $120 from $110, while reaffirming a Buy rating. The stock, currently trading near its ...

Truist Securities adjusted its outlook on TTM Technologies (NASDAQ:TTMI), a leading global printed circuit board (PCB) manufacturer, by increasing the price target to $38.00, up from the previous $32.

gave Truist some capital cushion to offset the impact of a balance-sheet restructuring that dinged its capital. The bank recorded a $5.1 billion after-tax loss under the restructuring, which involved ...

and $700,000 in deferred compensation or a change in pension value, according to Truist’s last annual proxy statement. Cummins will be eligible for his annual cash incentive-compensation award ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

with some subsectors offering value opportunities. Earnings growth, particularly in industrial, lodging, and triple-net REITs, is forecast to accelerate this year. Truist flagged interest rate ...

According to Truist, while bank valuations have increased, they remain relatively attractive compared to historical levels. They currently trade at a price-to-book value (P/TBV) below their post ...

Trading at a reasonable 10 times estimated 2025 earnings, this company looks sensible in a volatile stock market and trades at less than one times book value. Truist Securities has set an $85 ...

Truist's updated fiscal 2025 earnings projections are in a range of 3% to 3.5% on total revenues, with Marinac's at 3.3% total revenue. "Our fair value is $50 per share," Marinac said. Truist ...